Paola Castro-Garcia, “C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells”, J. Anal. Oncol., vol. 2, no. 4, pp. 195–208, Dec. 2013.